• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assays
      • Transcreener® ADP² Kinase Assay
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay
      • Transcreener® cGAMP cGAS Assay
      • Transcreener® GDP GTPase Assay Kits
      • Transcreener® UDP² Glycosyltransferase Assay
      • Transcreener® EPIGEN SAH Methyltransferase Assay
    • AptaFluor® HTS Assays
      • AptaFluor® SAH Methyltransferase Assay
    • HTS Assays by Target
      • Kinase Assay Kits
      • ATPase Assay Kits
      • cGAS Assay Kits
      • CD39 Assay Kits
      • CD73 Assay Kits – Coming Soon!
      • EZH2 Assay Kits
      • Glycosyltransferase Assay Kits
      • Phosphodiesterase Assay Kits
      • Ligase and Synthetase Assay Kits
      • Methyltransferase Assay Kits
      • GTPase Assay Kits
      • GAP Assay Kits
      • GEF Assay Kits
    • Ordering Information
  • Therapeutics
    • Pipeline
    • Scientific Advisory Board
  • Resources
    • Application Notes
    • Transcreener® Assays – Instrument Compatibility
    • Posters and Presentations
    • Publications
    • Technical Manuals
    • Transcreener® FAQ’s
    • Residence Time Guide
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

Tag: kinase assay

Finding Inhibitors for a Cancer Target: CDK12 Activity Assays Accelerate the Search

Tuesday, 03 December 2019 by Bellbrook Labs
CDK12 Activity Assays Find Inhibitors Cancer Treatment
All systems within our bodies function by means of proteins. When these proteins aren’t made correctly, our body malfunctions.  The short explanation: DNA is at the fabric of forming a functional protein; genes (made of DNA) get transcribed and then translated to become proteins. During this complex process, genes are not always correctly transcribed and
CDK12 Activity Assayskinase assayTranscreener ADP Kinase Assay
Read more
  • Published in Emerging Targets, HTS Assays
No Comments

Using TBK1 Inhibitors to Stop Cancer in Its Tracks

Tuesday, 29 October 2019 by Bellbrook Labs
Scientist Working on TBK1 Inhibitors for Cancer Research
TBK1 Inhibitors, Autoimmune Disorders, and Cancer – Inflammation is a crucial step within the immune response, helping our bodies eliminate disease. However, it can also be a burden where misregulation creates a variety of maladies including cancer. As inflammation persists, becoming chronic, the beneficial elements can be lost and disease occurs. It’s not just autoimmune
kinase assayTBK1 InhibitorsTranscreener ADP Kinase Assay
Read more
  • Published in Emerging Targets
No Comments

How a Tyrosine Kinase Inhibitor Is Giving Hope to Lung Cancer Patients

Tuesday, 20 August 2019 by Bellbrook Labs
tyrosine kinase inhibitor lung cancer
According to the American Cancer Society, lung cancer is the leading cause of cancer death each year and accounts for approximately 13% of all new cases. The most common type being non-small cell lung cancer (NSCLC). Although smoking is the biggest contributor, other factors such as genetics and environmental pollutants contribute to lung cancer of
kinase assayTranscreener ADP Kinase Assaytyrosine kinase inhibitors
Read more
  • Published in Emerging Targets
No Comments

How Does a Biochemical Kinase Assay Work?

Monday, 10 December 2018 by Bellbrook Labs
What is a kinase assay
A kinase assay works by simply measuring the activity of the kinase. A kinase is an enzyme that aids in the transfer of a phosphate from ATP to another specific molecule. They regulate many activities in the human body. The measurement is used to test potential drugs to see how they affect kinase activity. An
kinase assay
Read more
  • Published in HTS Assays
No Comments

Transcreener ADP Assay Enables Evaluation of NIK Inhibitors in Lupus Drug Discovery

Wednesday, 07 November 2018 by Bellbrook Labs
Lupus NIK Inhibitors
  Systemic lupus erythematosus (SLE), or lupus, takes a devastating toll. An autoimmune disease that triggers a dysfunctional immune system to attack its own tissues, SLE strikes young women most often — about 4 to 12 times more frequently than men — with women aged 15 to 45 being at highest risk. Both genetic and
kinase assayNIK InhibitorsTranscreener ADP Kinase Assay
Read more
  • Published in HTS Assays, Success Stories
No Comments

Doubling the Odds: Two-Pronged Strategy to Halt Cancer Cell Proliferation

Wednesday, 29 November 2017 by Bellbrook Labs
It would be difficult to underestimate the importance of polo-like kinase 1 (Plk1) for cancer, given its influence on cell division. As one of five members of the Polo-like family of serine/threonine protein kinases in eukaryotic cells, Plk1 plays a multifaceted role in the cell cycle and thus controls cancer progression fueled by unchecked cell
Assay Development Servicesdrug discovery serviceskinase assayTranscreener ADP Kinase Assay
Read more
  • Published in HTS Assays, News, Uncategorized
No Comments

Newly Patented Aurora A Kinase Inhibitor a Promising Contender for Cancer Treatment

Wednesday, 15 November 2017 by Bellbrook Labs
Aurora A Kinase in Cancer Drug Development Aurora A Kinase, along with -B and -C, are members of a family of serine/threonine protein kinases that play critical roles in coordinating mitosis, including establishment of the mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. The enzyme’s role
Assay Development Servicesdrug discovery serviceskinase assayLead Discovery ServicesTranscreener ADP Kinase Assay
Read more
  • Published in HTS Assays, News, Products, Success Stories
No Comments

Taking Up Residence: Using the Transcreener ADP Assay to Measure the Kinetics of Kinase Inhibitor Interactions

Wednesday, 30 August 2017 by Bellbrook Labs
Classically speaking, assays for interactions between drug molecules and their targets have measured binding affinity under equilibrium conditions. In drug discovery projects, it had long been assumed that carefully measuring IC50 (half-maximal inhibitory concentration), EC50 (effector concentration for half-maximal response), Kd  (equilibrium dissociation constant), and/or Ki (inhibition constant) would allow drug candidates to be prioritized
Assay Development Servicesdrug discovery serviceskinase assayLead Discovery ServicesResidence TimeTranscreener ADP Kinase Assay
Read more
  • Published in HTS Assays, Uncategorized
No Comments

Kinase Assays and Applications in Cancer Therapeutic Discovery

Wednesday, 30 November 2016 by Bellbrook Labs
The ABL1 gene is a special type of gene that encodes a protein tyrosine kinase. It is involved in various cellular processes, including but not limited to cell adhesion, cell division, and cell differentiation. This protein’s activity is adversely regulated by its SH3 domain, which involves the deletion of the region that encodes the domain
Kinasekinase assay
Read more
  • Published in HTS Assays
No Comments

ICBS Conference 2016

Thursday, 06 October 2016 by Bellbrook Labs
  Location: Madison, WI Date: October 24-26   BellBrook Labs’ team of scientists will be presenting the following posters at the International Chemical Biology Society. A Homogenous, Universal Methyltransferase Assay Based on a Microbial Riboswitch Leveraging Aptamers for Detection of Growth Factors in an HTS Compatible Format: An AptaFluor™ VEGF Assay Measuring Drug Residence Times
ICBSkinase assay
Read more
  • Published in Company, News
No Comments
  • 1
  • 2

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • CDK12 Activity Assays Find Inhibitors Cancer Treatment

    Finding Inhibitors for a Cancer Target: CDK12 Activity Assays Accelerate the Search

    All systems within our bodies function by means...
  • New Transcreener cGAS Assay

    BellBrook Labs Launches Transcreener cGAS Activity Assay to Accelerate Drug Discovery

    The new Transcreener cGAMP cGAS Assay directly ...
  • Fighting Ovarian Cancer ST3GAL1 Inhibitors

    Helping Fight Ovarian Cancer with ST3GAL1 Inhibitors

    Important functions such as cell–cell recogniti...
  • Scientist Working on TBK1 Inhibitors for Cancer Research

    Using TBK1 Inhibitors to Stop Cancer in Its Tracks

    TBK1 Inhibitors, Autoimmune Disorders, and Canc...
  • ENPP1 Inhibitors Improve Innate Immunity

    ENPP1 Inhibitors, Assays, and Innate Immunity

    The human immune response is incredible. Unlike...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2019 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP